Literature DB >> 10424443

Interleukin-12 and interleukin-10 production by mononuclear phagocytic cells from breast cancer patients.

R A Merendino1, S Gangemi, A Misefari, A Arena, A B Capozza, S Chillemi, F P D'Ambrosio.   

Abstract

Interleukin-10 (IL-10) and Interleukin 12 (IL-12) generation may be regulated by a complex monocyte and macrophage-derived cytokine network and an impairment of the immune system can be observed in neoplastic disease. In this study, we examined the production of these cytokines by phagocytic cells, obtained from breast cancer (BCa)-bearing patients. Our results suggest that an increased IL-10 formation may represent an important regulatory pathway of IL-12 production by BCa mononuclear cells. In this report, we show that mononuclear cells of patients affected by breast cancer have a defective IL-12 production capability while generating higher amounts of IL-10.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10424443     DOI: 10.1016/s0165-2478(99)00067-x

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  9 in total

1.  Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma.

Authors:  Lars-A Ormandy; Anatol Farber; Tobias Cantz; Susanne Petrykowska; Heiner Wedemeyer; Monique Horning; Frank Lehner; Michael-P Manns; Firouzeh Korangy; Tim-F Greten
Journal:  World J Gastroenterol       Date:  2006-05-28       Impact factor: 5.742

2.  A Survey on the Role of Interleukin-10 in Breast Cancer: A Narrative.

Authors:  Elnaz Sheikhpour; Parisa Noorbakhsh; Elnaz Foroughi; Soudabeh Farahnak; Rezvan Nasiri; Hossein Neamatzadeh
Journal:  Rep Biochem Mol Biol       Date:  2018-10

3.  Association between the expression of IL-10 and T cell activation proteins loss in early breast cancer patients.

Authors:  Leticia Llanes-Fernández; Maria del Carmen Arango-Prado; Juan Manuel Alcocer-González; Marta Elena Guerra-Yi; Sonia Franco-Odio; Rolando Camacho-Rodríguez; Vicente Madrid-Marina; Reyes Tamez-Guerra; Cristina Rodríguez-Padilla
Journal:  J Cancer Res Clin Oncol       Date:  2008-07-24       Impact factor: 4.553

4.  Serum IL-8 and IL-12 levels in breast cancer.

Authors:  Duygu Derin; Hilal Oguz Soydinc; Nese Guney; Faruk Tas; Hakan Camlica; Derya Duranyildiz; Vildan Yasasever; Erkan Topuz
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

5.  Plasma PGE-2 levels and altered cytokine profiles in adherent peripheral blood mononuclear cells in non-small cell lung cancer (NSCLC).

Authors:  Giovanna E Hidalgo; Li Zhong; Dennis E Doherty; Edward A Hirschowitz
Journal:  Mol Cancer       Date:  2002-11-12       Impact factor: 27.401

6.  Clinical Significance of Serum IL-12 Level in Patients with Early Breast Carcinoma and Its Correlation with Other Tumor Markers.

Authors:  Samar Samir Youssef; Manal Moussa Mohammad; Lobna R Ezz-El-Arab
Journal:  Open Access Maced J Med Sci       Date:  2015-11-03

7.  Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review.

Authors:  S P Balasubramanian; I A F Azmy; S E Higham; A G Wilson; S S Cross; A Cox; N J Brown; M W Reed
Journal:  BMC Cancer       Date:  2006-07-14       Impact factor: 4.430

8.  Altered maturation of peripheral blood dendritic cells in patients with breast cancer.

Authors:  S Della Bella; M Gennaro; M Vaccari; C Ferraris; S Nicola; A Riva; M Clerici; M Greco; M L Villa
Journal:  Br J Cancer       Date:  2003-10-20       Impact factor: 7.640

9.  Benefits in radical mastectomy protocol: a randomized trial evaluating the use of regional anesthesia.

Authors:  Marcio Matsumoto; Eva M Flores; Pedro P Kimachi; Flavia V Gouveia; Mayra A Kuroki; Alfredo C S D Barros; Marcelo M C Sampaio; Felipe E M Andrade; João Valverde; Eduardo F Abrantes; Claudia M Simões; Rosana L Pagano; Raquel C R Martinez
Journal:  Sci Rep       Date:  2018-05-18       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.